搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 24 小时
时间不限
过去 1 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
19 小时
FDA批准新型口服抗生素ORLYNVAH用于治疗非复杂性尿路感染
都柏林和芝加哥 - Iterum Therapeutics plc (NASDAQ:ITRM) 今天宣布,美国食品和药物管理局(FDA)已批准其新药申请ORLYNVAH™(sulopenem etzadroxil和probenecid)。该药物适用于治疗成年女性的非复杂性尿路感染(uUTIs),特别是由大肠杆菌、肺炎克雷伯菌或奇异变形杆菌引起的感染。ORLYNVAH™是美国首个获批的口服青霉烯类抗 ...
腾讯网
5 小时
首款!FDA批准创新小分子药物上市
IterumTherapeutics今日宣布,美国FDA已批准其药品Orlynvah(sulopenem etzadroxil & ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
Grateful Dead bassist dies
DOJ reaches settlement
DNA tests identify skull
World's most valuable firm
Strike kills 3 journalists
Gaza peace talks to resume?
Apology for past US policy
Murder-for-hire plot arrest
Browns sue city of Cleveland
NASA astronaut hospitalized
Recalls chicken products
Approves Iterum's treatment
Announces layoffs, jet sales
Madigan corruption trial
Arlington incident report
CO ballots to be reexamined
Exonerated after 22 years
Phones hacked by China?
Dismissal of charge upheld
New student loan relief plan
Jeffries pleads not guilty
Louisiana forces relocation
SC teen voting glitch
Sentenced for Jan. 6 role
Hit w/ discrimination claims
VA voter roll purge blocked
ABC News icon Jarriel dies
Won't endorse candidates
Israel strikes back at Iran
PA registration fraud probe
反馈